Sponsors and CROs both have key role in quality; FDA

By Nick Taylor

- Last updated on GMT

Related tags: Contract research organization

The FDA is emphasising the key role both sponsors and CROs play in ensuring high quality clinical trials.

Outsourcing of clinical trials presents the US Food and Drug Administration (FDA) and companies with new issues around quality and responsibilities. By properly transferring responsibilities to contract research organisations (CRO) sponsors can eliminate some potential problems.

A sponsor has to indicate what specific responsibilities they’re transferring to the CRO in writing. Anything that’s not specifically described in writing is deemed to be retained by the sponsor​”, Ann Meeker O’Connell, acting associate director at the FDA, told Outsourcing-Pharma.

Sponsors encounter problems when there is “a lack of clarity in the transfer of obligations​”. Other problems can arise when a sponsor only provides limited real-time oversight in managing the CRO.

Meeker O’Connell goes on to list four areas sponsors must address to ensure a smooth transfer of responsibilities to a CRO. While this is important, sponsors must remember they “retain the ultimate responsibility for the quality and integrity of any data…that are submitted to the FDA​”.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars